Navigation Links
Honeywell's Envergent Technologies Selected by Malaysian Company for Renewable Energy Project
Date:3/10/2011

DES PLAINES, Ill., March 10, 2011 /PRNewswire/ -- Envergent Technologies LLC, a Honeywell (NYSE: HON) company, announced today that it has been selected by Premium Renewable Energy (Malaysia) Sdn. Bhd. to perform the engineering design for a project that will use Envergent's RTP® Rapid Thermal Processing technology to convert palm biomass to renewable heat and electricity.

The initial Premium RTP facility, to be initiated in late 2011 and completed in early 2013, will be Malaysia's first plant to use RTP for the production of a clean-burning liquid biofuel derived from biomass. The RTP liquid fuels will be used to generate renewable electricity and heat.

Premium expects that the first facility will be followed by additional RTP units to be built by 2020.

"This project is a milestone using palm biomass, particularly the empty fruit bunches, to generate renewable heat and power and demonstrates how Envergent's technology can be used in different regions with a variety of feedstocks," said Dave Cepla, managing director for Honeywell's Envergent Technologies joint venture. "We are proud to support Premium Renewable Energy in creating RTP plants that will not only reduce the carbon footprint in Malaysia, but will also help grow the economy."

The project is part of the Malaysian government's Economic Transformation Program for the palm oil sector in order to create a high-income economy by 2020 while growing in a sustainable manner. The project is projected to create 1,000 new jobs and generate $1 billion in revenue annually by 2020.

Envergent will perform a site assessment and identify strategies for integration for the facility into the existing palm oil industry in Malaysia. It will also provide equipment scoping, engineering design, a constructability analysis and a plant construction schedule for the RTP unit in support of Premium's plan.

Envergent's RTP technology works by rapidly heating biomass at ambient pressure to generate high yields of a liquid biofuel, which can be used to power electric generators or burned in industrial burners and furnaces for heat. Using this biofuel will help reduce greenhouse gas emissions and dependence on fossil fuels.

Envergent Technologies is a joint venture of Honeywell's UOP and Ensyn Corp. It combines nearly 100 years of refining and process technology development from UOP and more than 25 years of biomass technology experience from Ensyn Corp. RTP is currently in use in seven commercial biomass processing plants in the U.S. and Canada.

In addition to the use of biomass for renewable power and heat, Envergent Technologies is also focused on development and commercialization of technology to upgrade the biofuel produced into green transportation fuels. A demonstration unit of this technology is currently in engineering design in Kapolei, Hawaii under a grant from the United States Department of Energy.  

Honeywell's UOP is a leading supplier and licensor of process technology, catalysts, adsorbents and services to the petroleum refining, petrochemical, and gas processing industries. It has been active in the development and licensing of renewable fuel technologies since 2006. Learn more about the Envergent Technology joint venture at www.EnvergentTech.com

Premium Renewable Energy (Malaysia) Sdn. Bhd is a Malaysian company formed in partnership with Ensyn Corp.  Premium has the exclusive rights to commercialize the proven RTP® technology in Malaysia and other parts of the region for the production of renewable liquid fuels from biomass for heat, power and green transportation fuels.

Honeywell International (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; automotive products; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell's shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.

This release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management's assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Envergent Technologies LLC, a Honeywell company
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Honeywells Envergent Technologies to Demonstrate Renewable Fuel for Heat & Power at Crane & Companys Massachusetts Headquarters
2. Palatin Technologies, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
3. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2010 Financial Results on March 11, 2011
4. Reportlinker Adds Biomarkers - Technologies, Markets and Companies
5. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
6. Reportlinker Adds RNAi - Technologies, Markets and Companies
7. BioSpecifics Technologies Corp. to Present at Cowen and Company 31st Annual Health Care Conference
8. Calipers Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
9. Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board
10. Seahorse Bioscience, Inc. Appoints In Vitro Technologies Pty Ltd as New Distributor in Australia and New Zealand
11. Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Life Sciences & Diagnostics Bus Trip
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 /PRNewswire/ ... the formation of its Medical/Clinical Advisory Board.  This ... veterans who enhance the range and depth of ... of its novel prenatal diagnostic tests.  These experts ... strategic guidance for the company,s product development and ...
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... Staten Island, NY (PRWEB) , ... January 19, 2017 , ... ... expand at an exponential rate. The tremendous growth is accounted to two main ... to the table and the expanding network of vendors supplying FireflySci products all around ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... live webcast of its Annual Meeting of Shareholders on Tuesday, January ... can be accessed from the BD corporate website at http://www.bd.com/investors/ ... ... BD is a global medical technology company that is ...
Breaking Biology Technology:
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
Breaking Biology News(10 mins):